|
Federal Register
Notices
> Notice of Registration - 2009
>
Sigma Aldrich Research Biochemicals, Inc.
FR Doc E9-13358[Federal Register: June 9, 2009 (Volume 74, Number 109)]
[Notices] [Page 27350-27351] From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr09jn09-106]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated February 13, 2009, and published in the Federal Register on
February 20, 2009, (74 FR 7924), Sigma Aldrich Research Biochemicals, Inc., 1-3
Strathmore Road, Natick,
[[Page 27351]]
Massachusetts 01760-2447, made application by renewal to the Drug Enforcement
Administration (DEA) to be registered as a bulk manufacturer of the basic
classes of controlled substances listed in schedules I and II:
|
Drug
|
Schedule
|
|
Cathinone (1235)
|
I
|
|
Methcathinone (1237)
|
I
|
|
Aminorex (1585)
|
I
|
|
Gamma Hydroxybutyric Acid (2010)
|
I
|
|
Alpha-ethyltryptamine (7249)
|
I
|
|
Lysergic acid diethylamide (7315)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
4-Bromo-2,5-dimethoxyamphetamine (7391)
|
I
|
|
4-Bromo-2,5-dimethoxyphenethylamine (7392)
|
I
|
|
2,5-Dimethoxyamphetamine (7396)
|
I
|
|
3,4-Methylenedioxyamphetamine (7400)
|
I
|
|
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)
|
I
|
|
3,4-Methylenedioxy-N-ethylamphetamine (7404)
|
I
|
|
3,4-Methylenedioxymethamphetamine (MDMA)(7405)
|
I
|
|
Psilocybin (7437)
|
I
|
|
5-Methoxy-N,N-diisopropyltryptamine (7439)
|
I
|
|
1-[1-(2-Thienyl)cyclohexyl]piperidine (TCP)(7470)
|
I
|
|
1-Benzylpiperazine (BZP) (7493)
|
I
|
|
Heroin (9200)
|
I
|
|
Normorphine (9313)
|
I
|
|
Amphetamine (1100)
|
II
|
|
Methamphetamine (1105)
|
II
|
|
Nabilone (7379)
|
II
|
|
1-Phenylcyclohexylamine (7460)
|
II
|
|
Phencyclidine (7471)
|
II
|
|
Cocaine (9041)
|
II
|
|
Codeine (9050)
|
II
|
|
Diprenorphine (9058)
|
II
|
|
Ecgonine (9180)
|
II
|
|
Levomethorphan (9210)
|
II
|
|
Levorphanol (9220)
|
II
|
|
Meperidine (9230)
|
II
|
|
Metazocine (9240)
|
II
|
|
Methadone (9250)
|
II
|
|
Morphine (9300)
|
II
|
|
Thebaine (9333)
|
II
|
|
Levo-alphacetylmethadol (9648)
|
II
|
|
Carfentanil (9743)
|
II
|
|
Fentanyl (9801)
|
II
|
The company plans to manufacture reference standards.
No comments or objections have been received. DEA has considered the factors
in 21 U.S.C. 823(a) and determined that the registration of Sigma Aldrich
Research Biochemicals, Inc. to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this time. DEA
has investigated Sigma Aldrich Research Inc. to ensure that the company's
registration is consistent with the public interest. The investigation has
included inspection and testing of the company's physical security systems,
verification of the company's compliance with State and local laws, and a review
of the company's background and history. Therefore, pursuant to 21
U.S.C. 823, and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic class of controlled substance listed.
Dated: June 3, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-13358 Filed 6-8-09; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
|
